ClinicalTrials.gg
CompletedNCT02815306Updated Jun 28, 2016

Polyaxial Brace Fixing for the Treatment of Congenital Clubfoot

An interventional study of Polyaxial brace in Clubfoot, sponsored by Children's Hospital of Chongqing Medical University. Completed. Open to participants aged 1 Day to 3 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2016-06-28.

Sponsored by Children's Hospital of Chongqing Medical University · Not applicable, Interventional, and Treatment

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
88
Allocation
Not applicable
Ages
1 Day to 3 Years
Sex
All
01

Study summary

Congenital idiopathic clubfoot (CC) is the fifth most common congenital malformation in children. The Ponseti method is an effective protocol for treatment of congenital idiopathic clubfoot. Plaster is essential for the Ponseti treatment. This paper describes a new brace that can be used for the treatment of clubfoot in newborns and infants instead of plaster.

Read the detailed description

Methods In the orthopedic department of our hospital, 38 infants and newborns, (57 feet) ,all the patients were under the age of 3 months with congenital clubfoot underwent polyaxial braces between Jan, 2011 to Oct ,2013. Polyaxial brace was used for the deformity correction. Then, during the following 1-3 years, the Dennis braces were used during the night in case of recurrence. Prospective follow-up for a mean duration of 25 months (range, 15-36months) was carried out. The efficacy of the treatment was assessed by Pirani's scoring system before and after treatment.

02

Conditions studied

  • Clubfoot

Browse trials for

Keywords

  • Congenital idiopathic clubfoot
  • Pirani score
  • infant
  • polyaxial brace
03

In context

Clubfoot

69 studies on the registry are indexed under Clubfoot; 15 are open to participants now.

This study's enrollment of 88 is above the median of 38 across 40 interventional studies indexed under Clubfoot.

Browse Clubfoot studies →

Lead sponsor

Children's Hospital of Chongqing Medical University is the lead sponsor of 35 studies on the registry; 13 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
1 Day to 3 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

0-6 months infants parents would like to cooperate with the doctors.

Exclusion criteria

Exclusion Criteria:

over 6 months.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
88 participants (actual)

Study arms

  • Experimental
    Brace goup

    The infants who were brace group treated by braces which were designed and made by us.

    Device: Polyaxial brace

Interventions

  • DevicePolyaxial brace

    The Polyaxial brace were made by a technician trained by the China National Disabled Persons Federation. For all patients, gypsum models were prepared first, and then braces were fabricated according to the models. The detailed technique was fully in accordance with the Ponseti method.

06

What researchers measure

Primary outcomes

  1. hindfoot

    severity of the posterior crease, emptiness of the heel and rigidity of the equinus

    Time frame: 1 month

  2. midfoot

    curvature of the lateral border of the foot, severity of the medial crease and position of the lateral part of the head of the talus

    Time frame: 1 month

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Mar 2011, a primary completion of Oct 2013 and a completion of Oct 2013. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 24, 2016
First posted
Jun 28, 2016
Start
Mar 2011
Primary completionActual
Oct 2013
CompletionActual
Oct 2013
Last update
Jun 28, 2016
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 28, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02815306
Lead sponsor
Children's Hospital of Chongqing Medical University
Responsible party
Guoxin Nan (Chief of the orthopeadic deapartment, Children's Hospital of Chongqing Medical University) — Principal investigator
First posted
Jun 28, 2016
Start date
Mar 2011
Primary completion
Oct 2013
Completion
Oct 2013
Last update
Jun 28, 2016

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion